TELMISARTAN 80mg. IP

An anti-hypertensive drug that lowers blood pressure and helps prevent strokes, heart attacks, and kidney problems. Provides better long-term compliance and better blood pressure control than enalapril. (J Amerena, 2002) A beneficial therapeutic option in the management of patients with hypertension. (M Sharpe, 2001) An effective and well-tolerated agent in the treatment of mild-to-moderate hypertension, producing sustained 24-hour blood pressure control. (J Mallion, 1999) More effective than atenolol 50 mg in lowering systolic blood pressure in patients with mild-to-moderate hypertension. (L Alcocer, 2004) More effective than losartan in reducing seated systolic blood pressure (22.1 vs. 16.5 mmHg) and standing systolic blood pressure (21.0 vs. 16.3 mmHg). (Y T Lee, 2004) Provides superior control of BP than losartan and has no association with increased risk of adverse events. (Gui-Lin Xi, 2008) A promising drug for controlling hypertension and reducing vascular risk in high-risk elderly patients with new-onset diabetes. (Jugdutt, 2010) Produces a greater reduction reduce BP than valsartan therapy in patients with hypertension. (Hisato Takagi & Group, 2013) A good candidate for blood pressure control in patients with essential hypertension and comorbid conditions such as diabetes, metabolic syndrome, dyslipidemia, or renal disease. (Mohammed Yunus Khan, 2021) More effective antihypertensive treatment than ramipril 10 mg in patients with mild-to-moderate hypertension. (Yves Lacourcière, 2006)